Literature DB >> 11189819

Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.

T Diaz1, D C Des Jarlais, D Vlahov, T E Perlis, V Edwards, S R Friedman, R Rockwell, D Hoover, I T Williams, E R Monterroso.   

Abstract

OBJECTIVES: This study examined correlates of prevalent hepatitis C virus (HCV) infection among young adult injection drug users in 2 neighborhoods in New York City.
METHODS: Injection drug users aged 18 to 29 years were street recruited from the Lower East Side and Harlem. Participants were interviewed about drug use and sex practices; venipuncture was performed for hepatitis B virus (HBV), HCV, and HIV serologies.
RESULTS: In both sites, testing positive for HCV antibody (anti-HCV) was associated with having injected for more than 3 years. Additionally, HCV infection was positively associated with injecting with someone known to have had hepatitis (but the association was significant only in the Lower East Side) and with sharing cotton (but the association was statistically significant only in Harlem). Being in drug treatment and older than 24 years were associated with HCV in the Lower East Side but not in Harlem. Receiving money for sex was associated with anti-HCV positivity in Harlem but not in the Lower East Side.
CONCLUSIONS: Several differences in factors associated with prevalent HCV infection existed among 2 populations of young injection drug users from the same city. Indirect transmission of HCV may occur.

Entities:  

Mesh:

Year:  2001        PMID: 11189819      PMCID: PMC1446499          DOI: 10.2105/ajph.91.1.23

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  28 in total

1.  Sociometric risk networks and risk for HIV infection.

Authors:  S R Friedman; A Neaigus; B Jose; R Curtis; M Goldstein; G Ildefonso; R B Rothenberg; D C Des Jarlais
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

2.  Self-reports of HIV risk behavior by injecting drug users: are they reliable?

Authors:  M F Goldstein; S R Friedman; A Neaigus; B Jose; G Ildefonso; R Curtis
Journal:  Addiction       Date:  1995-08       Impact factor: 6.526

3.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

Authors:  R S Garfein; D Vlahov; N Galai; M C Doherty; K E Nelson
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

4.  Methadone maintenance and hepatitis C virus infection among injecting drug users.

Authors:  N Crofts; L Nigro; K Oman; E Stevenson; J Sherman
Journal:  Addiction       Date:  1997-08       Impact factor: 6.526

5.  Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.

Authors:  K Stark; R Müller; U Bienzle; I Guggenmoos-Holzmann
Journal:  AIDS       Date:  1996-03       Impact factor: 4.177

6.  Annotation: needle exchange programs--do they work?

Authors:  R A Coutinho
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

7.  A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.

Authors:  E J Van Ameijden; J A Van den Hoek; G H Mientjes; R A Coutinho
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

8.  High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors.

Authors:  A Neaigus; S R Friedman; B Jose; M F Goldstein; R Curtis; G Ildefonso; D C Des Jarlais
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-04-15

9.  Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence.

Authors:  G Rezza; L Sagliocca; M Zaccarelli; M Nespoli; M Siconolfi; C Baldassarre
Journal:  Scand J Infect Dis       Date:  1996

Review 10.  Correlates of hepatitis C virus infections among injection drug users.

Authors:  D L Thomas; D Vlahov; L Solomon; S Cohn; E Taylor; R Garfein; K E Nelson
Journal:  Medicine (Baltimore)       Date:  1995-07       Impact factor: 1.889

View more
  58 in total

1.  Addressing urban health in Detroit, New York City, and Seattle through community-based participatory research partnerships.

Authors:  Marilyn M Metzler; Donna L Higgins; Carolyn G Beeker; Nicholas Freudenberg; Paula M Lantz; Kirsten D Senturia; Alison A Eisinger; Edna A Viruell-Fuentes; Bookda Gheisar; Ann-Gel Palermo; Donald Softley
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

Review 2.  The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research.

Authors:  Michael C Clatts; Lloyd Goldsamt; Alan Neaigus; Dorinda L Welle
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

3.  Drug use frequency among street-recruited heroin and cocaine users in Harlem and the Bronx before and after September 11, 2001.

Authors:  Stephanie H Factor; Yingfeng Wu; Joan Monserrate; Vincent Edwards; Yvonne Cuevas; Sandra Del Vecchio; David Vlahov
Journal:  J Urban Health       Date:  2002-09       Impact factor: 3.671

Review 4.  Updating the infection risk reduction hierarchy: preventing transition into injection.

Authors:  David Vlahov; Crystal M Fuller; Danielle C Ompad; Sandro Galea; Don C Des Jarlais
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

5.  Characteristics of drug users who witness many overdoses: implications for overdose prevention.

Authors:  Amy S B Bohnert; Melissa Tracy; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2011-08-12       Impact factor: 4.492

Review 6.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

7.  Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior.

Authors:  Holly Hagan; Jennifer V Campbell; Hanne Thiede; Steffanie A Strathdee; Lawrence Ouellet; Mary Latka; Sharon Hudson; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2007-03-23       Impact factor: 4.492

8.  Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program.

Authors:  Melissa R Stein; Irene J Soloway; Karen S Jefferson; Robert J Roose; Julia H Arnsten; Alain H Litwin
Journal:  J Subst Abuse Treat       Date:  2012-10-02

9.  Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico.

Authors:  Juan C Reyes; Héctor M Colón; Rafael R Robles; Eddy Rios; Tomás D Matos; Juan Negrón; Carmen Amalia Marrero; José M Calderón; Elizabeth Shepard
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

10.  Prevalence of and risk factors for hepatitis C virus infection among STD clinic clientele in Miami, Florida.

Authors:  J S Weisbord; M J Trepka; G Zhang; I P Smith; T Brewer
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.